← Evidence map

SynthesisThe Journal of antimicrobial chemotherapy2018

The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.

Michael G Whitfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29982641